ES547495A0 - Procedimiento para la produccion de anticuerpos monoclonales a ciclosporinas. - Google Patents

Procedimiento para la produccion de anticuerpos monoclonales a ciclosporinas.

Info

Publication number
ES547495A0
ES547495A0 ES547495A ES547495A ES547495A0 ES 547495 A0 ES547495 A0 ES 547495A0 ES 547495 A ES547495 A ES 547495A ES 547495 A ES547495 A ES 547495A ES 547495 A0 ES547495 A0 ES 547495A0
Authority
ES
Spain
Prior art keywords
cyclosporins
monoclonal antibodies
procedure
production
cyclosporine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES547495A
Other languages
English (en)
Other versions
ES8702949A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848425040A external-priority patent/GB8425040D0/en
Priority claimed from GB858515673A external-priority patent/GB8515673D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES547495A0 publication Critical patent/ES547495A0/es
Publication of ES8702949A1 publication Critical patent/ES8702949A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
ES547495A 1984-10-04 1985-10-02 Procedimiento para la produccion de anticuerpos monoclonales a ciclosporinas. Expired ES8702949A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848425040A GB8425040D0 (en) 1984-10-04 1984-10-04 Organic compounds
GB858515673A GB8515673D0 (en) 1985-06-20 1985-06-20 Organic compounds

Publications (2)

Publication Number Publication Date
ES547495A0 true ES547495A0 (es) 1987-01-16
ES8702949A1 ES8702949A1 (es) 1987-01-16

Family

ID=26288301

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547495A Expired ES8702949A1 (es) 1984-10-04 1985-10-02 Procedimiento para la produccion de anticuerpos monoclonales a ciclosporinas.

Country Status (15)

Country Link
EP (4) EP0198026B1 (es)
JP (1) JPH074269B2 (es)
KR (1) KR910002691B1 (es)
AT (1) ATE92501T1 (es)
AU (4) AU589917B2 (es)
CA (1) CA1309671C (es)
CY (2) CY1915A (es)
DE (2) DE3587505T2 (es)
DK (1) DK172037B1 (es)
ES (1) ES8702949A1 (es)
FI (1) FI93965C (es)
HK (2) HK78696A (es)
NO (1) NO173557C (es)
NZ (1) NZ213680A (es)
WO (1) WO1986002080A1 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5239057A (en) * 1987-03-27 1993-08-24 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
US5427960A (en) * 1987-03-27 1995-06-27 Abbott Laboratories Fluorescence polarization assay for cyclosporin A and metabolites and related immunogens and antibodies
EP0283801A3 (en) * 1987-03-27 1990-05-30 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
US5698448A (en) * 1988-12-02 1997-12-16 Soldin; Steven J. Immunosuppressive drug binding proteins and use
CA2004626A1 (en) * 1988-12-05 1990-06-05 Bernard F. Erlanger Derivatives of cyclosporine a, antibodies directed thereto and uses thereof
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
CA2048302A1 (en) * 1990-08-15 1992-02-16 Victoria P. Meucci Solubilization reagent for biological test samples
DE69116034T2 (de) * 1990-08-15 1996-06-20 Abbott Lab Immunotestreagenzien und Verfahren zur Bestimmung von Cyclosporin
ES2091301T3 (es) 1990-11-20 1996-11-01 Behringwerke Ag Inmunoensayo de ciclosporina.
GB9307491D0 (en) 1993-04-08 1993-06-02 Sandoz Ltd Organic compounds
USRE40596E1 (en) * 1993-04-08 2008-12-02 Novartis Ag Rapamycin assay
US6270957B1 (en) 1997-08-26 2001-08-07 Wisconsin Alumni Research Foundation Non-Imuunosuppressive cyclosporins and their use in the prevention and treatment of HIV infection
AU8918998A (en) * 1997-08-26 1999-03-16 Wisconsin Alumni Research Foundation Non-immunosuppressive cyclosporins and their use in the prevention and treatmentof hiv infection
US5990274A (en) 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
US6927208B1 (en) 1998-07-01 2005-08-09 Debiopharm S.A. Cyclosporin with improved activity profile
US6686454B1 (en) 1998-10-09 2004-02-03 Isotechnika, Inc. Antibodies to specific regions of cyclosporine related compounds
BR9914092A (pt) 1998-10-09 2001-06-12 Isotechnika Inc Processos para a produção de anticorpos a regiões especìficas de ciclosporina e metabólitos de ciclosporina
PL210841B1 (pl) 2001-10-19 2012-03-30 Isotechnika Inc Sposób wytwarzania mieszaniny izomerów (E) i (Z) ISATX247
CA2685830C (en) 2007-05-24 2012-12-18 Abbott Laboratories Immunoassays exhibiting reduced cross-reactivity with hydrophobic drug analyte metabolites
TW200932240A (en) 2007-10-25 2009-08-01 Astellas Pharma Inc Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
EP2282724B1 (en) * 2008-05-23 2018-09-05 The University Of British Columbia Modified drugs for use in liposomal nanoparticles
NZ594755A (en) 2009-01-30 2013-12-20 Enanta Pharm Inc Cyclosporin analogues for preventing or treating hepatitis c infection
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8367053B2 (en) 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8685917B2 (en) 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8349312B2 (en) 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
US8623814B2 (en) 2010-02-23 2014-01-07 Enanta Pharmaceuticals, Inc. Antiviral agents
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
WO2012145427A1 (en) 2011-04-18 2012-10-26 The Trustees Of Columbia University In The City Of New York Methods to treat cancer using cyclosporine and cyclosporine derivatives
WO2014085623A1 (en) 2012-11-28 2014-06-05 Enanta Pharmaceuticals, Inc. Novel [n-me-4-hydroxyleucine]-9-cyclosporin analogues
AU2014311346A1 (en) 2013-08-26 2016-03-17 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis C
WO2016073480A1 (en) 2014-11-03 2016-05-12 Enanta Pharmaceuticals, Inc. Novel cyclosporin analogues for preventing or treating hepatitis c infection
WO2016112295A1 (en) 2015-01-09 2016-07-14 Warp Drive Bio, Inc. Compounds that participate in cooperative binding and uses thereof
AU2016329064B2 (en) 2015-10-01 2023-10-19 Warp Drive Bio, Inc. Methods and reagents for analyzing protein-protein interfaces
US10907188B2 (en) 2016-04-12 2021-02-02 Ginkgo Bioworks, Inc. Compositions and methods for the production of compounds
US11479797B2 (en) 2016-10-28 2022-10-25 Ginkgo Bioworks, Inc. Compositions and methods for the production of compounds
WO2021091956A1 (en) 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
JP2022553857A (ja) 2019-11-04 2022-12-26 レボリューション メディシンズ インコーポレイテッド Ｒａｓ阻害剤
EP4054719A1 (en) 2019-11-04 2022-09-14 Revolution Medicines, Inc. Ras inhibitors
PE20231207A1 (es) 2020-09-15 2023-08-17 Revolution Medicines Inc Derivados indolicos como inhibidores de ras en el tratamiento del cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB211526A (en) 1922-09-22 1924-02-22 John Fletcher Holliday Improvements in and relating to chain grate stokers
US4210581A (en) 1975-11-04 1980-07-01 Sandoz Ltd. Organic compounds
CH614931A5 (es) * 1975-11-04 1979-12-28 Sandoz Ag
DE2819094A1 (de) 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
IE54936B1 (en) * 1980-02-14 1990-03-28 Sandoz Ltd A method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
IL62965A0 (en) 1980-07-17 1981-07-31 Scripps Miles Lab Inc Monoclonal antibodies to drugs and theri production
EP0056782B1 (en) * 1981-01-09 1984-08-01 Sandoz Ag Novel cyclosporins
CH667274A5 (de) 1984-03-23 1988-09-30 Sandoz Ag Cyclosporine, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB8407618D0 (en) 1984-03-23 1984-05-02 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
DK261386D0 (da) 1986-06-03
NZ213680A (en) 1990-05-28
AU4967185A (en) 1986-04-17
NO862177D0 (no) 1986-06-02
JPS62500383A (ja) 1987-02-19
WO1986002080A1 (en) 1986-04-10
HK124696A (en) 1996-07-19
KR870700637A (ko) 1987-12-30
JPH074269B2 (ja) 1995-01-25
EP0290762B1 (en) 1993-05-12
HK78696A (en) 1996-05-10
AU3914289A (en) 1989-10-26
NO173557C (no) 1993-12-29
FI862370A0 (fi) 1986-06-03
AU3914389A (en) 1989-11-16
DE3587505T2 (de) 1994-01-05
DE3587342D1 (en) 1993-06-17
CA1309671C (en) 1992-11-03
EP0198026A1 (en) 1986-10-22
CY1915A (en) 1985-09-27
AU589917B2 (en) 1989-10-26
DK261386A (da) 1986-06-03
EP0314861A1 (en) 1989-05-10
DK172037B1 (da) 1997-09-22
KR910002691B1 (ko) 1991-05-03
EP0198026B1 (en) 1993-08-04
FI93965B (fi) 1995-03-15
ATE92501T1 (de) 1993-08-15
EP0314862A1 (en) 1989-05-10
CY1927A (en) 1997-05-16
NO862177L (no) 1986-08-04
NO173557B (no) 1993-09-20
FI93965C (fi) 1995-06-26
EP0290762A1 (en) 1988-11-17
DE3587505D1 (de) 1993-09-09
AU3914189A (en) 1989-11-16
DE3587342T2 (de) 1993-12-02
FI862370A (fi) 1986-06-03
ES8702949A1 (es) 1987-01-16

Similar Documents

Publication Publication Date Title
ES547495A0 (es) Procedimiento para la produccion de anticuerpos monoclonales a ciclosporinas.
ES2091301T3 (es) Inmunoensayo de ciclosporina.
CA2267072A1 (en) Reconstituted human anti-hm1.24 antibody
FI991477A (fi) Menetelmä tolterodiinin valmistamiseksi
AU1520895A (en) Purified primate ctla-8 antigens and related reagents
AU4958590A (en) Novel derivatives of cyclosporine a, antibodies directed thereto and uses thereof
HK1023513A1 (en) Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods
MY104946A (en) Antigen antibody conjugate.
ES2123677T3 (es) Ligadores de maleinimida trifuncionales homobidentados y su uso en conjugados inmunologicamente activos.
AU7249198A (en) Substantially pure zonulin, a physiological modulator of mammalian tight junctions
AU576088B2 (en) Histamine derivatives, immunogen conjugates and antibodies raised thereto
EP0734451A4 (en) ENTEROTOXINS OF -i (SHIGELLA FLEXNERI) 2a
EP1026237A3 (en) Tau/neurofilament protein kinases pk40 & pk36
ES2173879T3 (es) Procedimiento para la preparacion de conjugados a base de un participe especifico en la fijacion y de una proteina que contiene hidratos de carbono
AU7796291A (en) High affinity antibodies to small peptides
AU2001242084A1 (en) Polysaccharide-polypeptide conjugate
AU2484488A (en) Method for the production of antigenic protein-hapten conjugates, and antibodies corresponding thereto
Rutner et al. Surface modified liposomes
RO89316A2 (ro) Hibrid triliniar de porumb(zea mays l.convar.indurata)"podu iloaiei 101"

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20061120